LIFETECH SCI.DL-00000125 - Asset Resilience Ratio
LIFETECH SCI.DL-00000125 (81X) has an Asset Resilience Ratio of 11.48% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does LIFETECH SCI.DL-00000125 carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how LIFETECH SCI.DL-00000125's Asset Resilience Ratio has changed over time. See shareholders equity of LIFETECH SCI.DL-00000125 for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down LIFETECH SCI.DL-00000125's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 81X market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €612.37 Million | 11.48% |
| Total Liquid Assets | €612.37 Million | 11.48% |
Asset Resilience Insights
- Moderate Liquidity: LIFETECH SCI.DL-00000125 has 11.48% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
LIFETECH SCI.DL-00000125 Industry Peers by Asset Resilience Ratio
Compare LIFETECH SCI.DL-00000125's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for LIFETECH SCI.DL-00000125 (2021–2024)
The table below shows the annual Asset Resilience Ratio data for LIFETECH SCI.DL-00000125.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.53% | €516.13 Million ≈ $603.41 Million |
€4.90 Billion ≈ $5.73 Billion |
+6.27pp |
| 2023-12-31 | 4.26% | €200.00 Million ≈ $233.82 Million |
€4.70 Billion ≈ $5.49 Billion |
-6.96pp |
| 2021-12-31 | 11.22% | €357.11 Million ≈ $417.50 Million |
€3.18 Billion ≈ $3.72 Billion |
-- |
About LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more